The ACO Show

141. Aligning Quality Measures - Improving the System for Clinicians and Patients

Josh and Brian are joined by Doug Jacobs, MD, MPH, Chief Transformation Officer in the Center for Medicare at the Centers for Medicare & Medicaid Services (CMS), and Michelle Schreiber, Deputy Director for the Centers for Clinical Standards and Quality at CMS, and Director of the Quality Measurement & Value-Based Incentives Group at CMS. In the first part of this quality-focused series, they discuss the work they are doing to align quality measures across CMS and improve the system to benefit both clinicians and patients. 

140. Leading a Legal Team at a Fast-Growing Health Care Company

Josh and Brian are joined by Phuong Phillips, Chief Legal Officer at Aledade, where they discuss her personal journey, what drew her to Aledade and how corporate legal teams and leadership interact.

139. Behind-The-Scenes of CEO and Investor Relationships

For this episode, Josh and Brian hand the helm to Aledade CEO and Co-Founder, Farzad Mostashari, MD, and Bryan Roberts, partner at Venrock and lead of Venrock’s investment in Aledade. They give a behind-the-scenes look into the conversations that go on between CEOs, board members and investors regarding the challenges of running companies and how to create long-term solutions.

Learn more about Bryan's "Roberts' Rules of Life (& Venture Capital)" here: bit.ly/3KXxT2G

138. Introducing Residents to Value-Based Care with Aledade FIRST

Josh and Brian talk with Dr. Mitch Edmondson, the lead physician for the Aledade FIRST program, and Dr. Caleena Longworth, a 2nd-year resident at St. Mark’s Hospital in Salt Lake City who’s participating in Aledade FIRST about this new program introducing medical residents to the benefits of physician-led value-based care.

137. The ABCs of Being a Health Care Company CFO

Josh and Brian are joined by Aledade’s Chief Financial Officer, John Doyle. John provides a brief recap on the recent J.P. Morgan Healthcare Conference, how Aledade’s alignment as a company drew him in, and the many factors companies take into consideration before going public.

136. Becoming a Public Benefit Corporation

Josh and Brian are joined by Aledade’s CEO and co-founder, Dr. Farzad Mostashari, and Amy Simmerman, a partner at Wilson Sonsini Goodrich & Rosati, to discuss the idea of a public benefit corporation - what it is and what it means, why Aledade has decided to become one, and what this means for the health care industry as a whole.

135. Pediatric Value-Based Care: Does It Work?

Value-based care is often more focused on adults, especially the elderly who have the most burden of illness and, on average, the highest health care costs. Josh is joined by Dr. Karin McLelland, a pediatrician in North Carolina, and Carissa Praytor, Manager of Medicaid Performance at Aledade, to discuss how Aledade’s pediatric ACO in North Carolina was able to enable more primary care and reduce costs for this often-overlooked population of our nation’s youngest patients.

134. Building a Care Management Program

Josh and Brian are joined by Dr. Sarah Mullins, co-owner of Stoney Batter Family Medicine in Wilmington, Delaware, and Senior Regional Medical Director at Aledade, to discuss the role of care management programs in value-based care, how to build and sustain them, and the value they provide to patients and practices.

133. The State of Medicare Advantage

Josh and Brian are joined by Mike Stanzione, Aledade’s Director of Medicare Advantage Network Performance, to discuss the state of Medicare Advantage (MA), its rapid growth, regulatory evolution, and how the Aledade model of care applies to MA.

132. Realizing the Full Potential of Primary Care in ACOs

Josh and Brian are joined by Dr. Asaf Bitton, executive director of Ariadne Labs, and Associate Professor of Medicine and Health Care Policy at Harvard Medical School and the Harvard T.H. Chan School of Public Health. They discuss the need to move to value-based care and change the payment structure. They also reflect on the historical underfunding and undervaluing of primary care.